Prevention and treatment of hepatitis B recurrence after liver transplantation

National Medical Journal of China

Volumn 88, Issue 9, 2008, Pages 606-609

  Zhang, Xiang Liang ^a   Zhu, Xiao Feng ^b   Shi, Hui Juan ^b   Cui, Shu Zhong ^b   Tang, Yun Qiang ^b   Ba, Ming Chen ^b   Wang, Jia Kang ^b   Wang, Bin ^b   Lu, Qin ^b   Zhao, Hong Yu ^b   Wu, Yin Bing ^b   Li, Mei Lu ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

HBV infection; Hepatitis B Immunoglobulin; Lamivudine; Liver transplantation

Indexed keywords

ADEFOVIR; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENE MUTATION; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RECURRENT INFECTION; REINFECTION; RETROSPECTIVE STUDY; SEROCONVERSION;

ADULT; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; LAMIVUDINE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 44649131527     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Todo S, Demetris AJ, Van Thiel. D, et al. Orthotopic liver transplantation of patients with hepatitis B virus-related liver disease. Hepatology, 1991,13:619-626.
2. O'Grady JG, Smith HM, Davies SE, et al Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol, 1992,14:104-111.
3. McMillan JS, Shaw T, Angus PW, et al. Effect of immunosuppressive and antiviral agents on Hepatitis B virus replication in vitro. Hepatology, 1995,22:36-43.
4. Ben-Ari Z, Daudi N, Klein A, et al. Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation. Am J Gastroenterol, 2003,98:151-159.
5. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl Med, 1993,329:1842-1847.
6. Dumortier J, Chevalier P, Scoazec JY, et al. Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results. Am J Transplant, 2003,3:999-1002.
7. Chinese source.
8. Han SH, Martin P, Edelstein M, et al. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transpl, 2003,9:182-187.
9. Walsh KM, Woodall T, Jamy P, et al. Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus. GUT, 2001,49:436-440.
10. Perrillo R, Schiff E, Yoshida E, et al. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatoloty, 2000,32:129-134.